Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Breast Neoplasms 8Neoplasms 7Lung Neoplasms 7Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Melanoma 3Skin Neoplasms 2Neoplastic Cells, Circulating 2Lung Diseases 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Brain Neoplasms 2von Hippel-Lindau Disease 1Weight Loss 1Uterine Cervical Neoplasms 1Sleep Apnea Syndromes 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Ovarian Insufficiency 1Pituitary Neoplasms 1Pancreatic Neoplasms 1Overweight 1Obesity, Morbid 1Obesity 1Nervous System Diseases 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1

Interventions

Sunitinib 5ripretinib 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Imatinib Mesylate 2Biopsy 2regorafenib 1binimetinib 1Temozolomide 1TAS-116 1Sorafenib 1Rogaratinib 1Poly(ADP-ribose) Polymerase Inhibitors 1Nivolumab 1Midazolam 1Ipilimumab 1CTLA-4 Antigen 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Gastrointestinal Stromal Tumors × Blood Specimen Collection × Clear all
NCT01991379 2025-12-04

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting
75 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡